entertainment -WSS

entertainment

author：focus 2025-09-30 00:01:13 - browse：89

The corporate offices of Massachusetts General Brigham hospitals in Assembly Square in Somerville. Lane Turner/Globe Staff

The severing of ties between two of Boston’s biggest health care giants has placed one of the nation’s largest health care systems in the position of figuring out how, exactly, to fill a new hole in its oncology services, at a time when cancer care is changing rapidly.

Earlier this month, Dana-Farber Cancer Institute surprised the medical community and even its partner, Brigham and Women’s Hospital, when it announced that it would end their nearly 30-year collaboration. The split will take a few years to play out — Dana-Farber and Brigham and Women’s have a contract into 2028 — but has shaken patients and physicians.

Anne Klibanski, chief executive of Brigham and Women’s parent organization, Mass General Brigham, placed the blame on Dana-Farber executives. The two parties had been in discussions about extending their contract for months when the split was announced. “The decision was made by the Farber. It was announced. Now, we just have to plan forward,” she said. Klibanski shared her views on the split at a meeting with Boston Globe opinion editors on Thursday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： How to increase colonoscopy rates? Looks like an AI can help

WSS

Kaiser's Risant Health gobbled up Geisinger. Who is next?

What the cancer research community can learn from the Covid response

HIV drugs protect against transmission, even in unprotected sex

A cyberattack has disrupted hospitals and health care in several states

2 US Navy sailors arrested for allegedly spying for China

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

leisure time

entertainment

knowledge

Heart attack and stroke risk calculators need revising

Innovation in antibiotics is ailing. 'Brain drain' may kill it

Novavax promises a turnaround & Lilly roils the obesity market

Cord blood banking comes at a high cost to babies

Moonlake's readout produced a cash windfall. Risks remain

Stem cell clinics for heart failure: buyer be wary

Drug repurposing or repositioning? The language matters

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

Alkermes shareholders re

NIH documents show early flaws of $1.6 billion long Covid program

leisure time

Shifting the focus from loneliness to social health

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Cord blood banking comes at a high cost to babies

What the cancer research community can learn from the Covid response

2 US Navy sailors arrested for allegedly spying for China

A cyberattack has disrupted hospitals and health care in several states

leisure time

knowledge

knowledge

Wikipedia